Vol. 18 No. 4 (2014): Heart Rhythm Disoders (Special Issue)
HEART RHYTHM DISORDERS

Occlusion of left atrial appendage in patients with atrial fibrillation

PDF (Русский)
  • O. Ganeeva
O. Ganeeva
Institute of Surgery named after A.V. Vishnevsky
Bio
DOI: https://doi.org/10.21688/1681-3472-2014-4-104-112

Published 2014-10-28

Keywords

  • ATRIAL FIBRILLATION,
  • STROKE,
  • THROMBOEMBOLIC EVENT,
  • APPENDAGE OCCLUSION

How to Cite

Ganeeva, O. (2014). Occlusion of left atrial appendage in patients with atrial fibrillation. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 18(4), 104–112. https://doi.org/10.21688/1681-3472-2014-4-104-112

Copyright (c) 2014 Ganeeva O.N.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

The article reviews a new method of prophylaxis of thromboembolitic complications, specifically occlusion of left atrial appendage, in patients with atrial fibrillation. Indications and contraindications for the procedure, as well as a step-by-step process of the intervention itself are described. Special emphasis is placed on the up-to-date evidence and the review of clinical trials.
PDF (Русский)

References

  1. Camm J., Lip G., Caterina R., et al. 2012 ESC Guidelines for the management of atrial fibrillation.
  2. Holmes D., Reddy V., Turi Z., et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fi brillation: a randomised non-inferiority trial. Lancet. 2009; 374: 534-42.
  3. Haensig M., Rastan A., Holzher D., et al. Cardiology Research and Practice. 2012; Article ID 149503, 8 p.
  4. Hart R., Pearce L., Aguilar M. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation. Ann Intern Med. 2007; 146: 857-67.
  5. Schulman S., Elbazi R., Zondag M., et al. Thrombosis Journal. 2008; 6: 15.
  6. Capodanno D., Capranzano P., Giacchi G., et al. Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation. A metaanalysis of 50,578 patients. International Journal of Cardiology. IJCA-14637; 5 p.
  7. Reddy V., Holmes D., Doshi S., et al. Safety of Percutaneous Left Atrial Appendage Closure: Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry. Circulation. 2011; 123: 417-24.
  8. Holmes D. Jr., Schwartz J. Left atrial appendage occlusion eliminates the need for warfarin. Circulation. 2009; 120: 1919-26.
  9. Holmes D., Kar S., Price M., et al. Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy. The PREVAIL Trial. J. Am. Coll. Cardiol. 2014; 64: 1-12.
  10. Kar S., Hou D., Jones R., et al. Impact of Watchman and Amplatzer Devices on Left Atrial Appendage Adjacent Structures and Healing Response in a Canine Model. JACC Cardiovascular Interventions. 2014; 7: 801-9.
  11. HRS LBCT 2013 by V. Reddy, HH-158101-AA-May 2013